fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

High blood pressure linked to reduced Alzheimer's risk, meds may be reason

Written by | 14 Jul 2015

A new study suggests that people with a genetic predisposition to high blood pressure have a lower risk for Alzheimer’s disease.

High blood pressure linked to reduced Alzheimer’s risk, meds may be reason

Written by | 14 Jul 2015

A new study suggests that people with a genetic predisposition to high blood pressure have a lower risk for Alzheimer’s disease.

World population gains more than 6 years of life

Written by | 15 Jan 2015

Despite global improvements in life expectancy, death rates for some causes — including drug use and liver cancer — continue to rise.  Global life expectancy increased by 5.8… read more.

Despite risks, benzodiazepine use highest in older people

Written by | 13 Jan 2015

National Institutes of Health-supported study examines prescribing patterns.  Prescription use of benzodiazepines, increases steadily with age, despite the known risks for older people, according to a comprehensive analysis… read more.

Is diabetes linked to cognitive impairment?

Written by | 23 Dec 2014

World Health Matters – Germany – by Gary Finnegan: Mild cognitive impairment (MCI) is twice as common in middle-aged people with diabetes mellitus type 2, according to researchers… read more.

Press Release: Tough decision for Roche following mixed Phase II Trial results for Alzheimer’s drug

Written by | 24 Jul 2014

Roche faces difficult decision over entering Alzheimer’s disease (AD) drug crenezumab for Phase III clinical trials. ‘The company should be encouraged by the drug’s demonstrated efficacy in mild… read more.

FDA Highlights: Could anti-depressant citalopram affect development of Alzheimer's?

Written by | 17 Jul 2014

by Bruce Sylvester – The selective serotonin reuptake inhibitor (SSRI) citalopram appears to impede development of amyloid beta, a plaque-forming peptide in the brain believed to be involved… read more.

FDA Highlights: Could anti-depressant citalopram affect development of Alzheimer’s?

Written by | 17 Jul 2014

by Bruce Sylvester – The selective serotonin reuptake inhibitor (SSRI) citalopram appears to impede development of amyloid beta, a plaque-forming peptide in the brain believed to be involved… read more.

Computer clusters new sub type asthma patients

Written by | 8 May 2014

Analysis could eventually lead to improved therapy, researcher says.  So many variables can contribute to shortness of breath that no person can keep them all straight. But a… read more.

FDA Highlights: Citalopram shows efficacy for Alzheimer's agitation

Written by | 14 Mar 2014

by Bruce Sylvester: The antidepressant citalopram (Celexa/Cipramil, and generic) significantly reduces agitation among patients with Alzheimer’s disease, researchers reported in the Feb. 19, 2014 issue of JAMA/Journal of… read more.

FDA Highlights: Citalopram shows efficacy for Alzheimer’s agitation

Written by | 14 Mar 2014

by Bruce Sylvester: The antidepressant citalopram (Celexa/Cipramil, and generic) significantly reduces agitation among patients with Alzheimer’s disease, researchers reported in the Feb. 19, 2014 issue of JAMA/Journal of… read more.

It’s all coming back to me now with coffee

Written by | 22 Jan 2014

For some, it’s the tradition of steeping tealeaves to brew the perfect cup of tea. For others, it’s the morning shuffle to a coffee maker for a hot… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.